AngioDynamics, Inc. reported consolidated Goodwill impairment for third quarter ended February 29, 2024. For the quarter, the company reported Goodwill impairment of $159,476,000.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.93 USD | +2.95% |
|
+0.17% | -24.36% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.36% | 24Cr | |
-4.92% | 18TCr | |
-3.70% | 10TCr | |
-5.29% | 6.67TCr | |
+10.99% | 4.49TCr | |
-7.70% | 4.56TCr | |
+6.13% | 4.06TCr | |
+15.96% | 3TCr | |
+14.80% | 2.43TCr | |
-6.63% | 2.39TCr |
- Stock Market
- Equities
- ANGO Stock
- News AngioDynamics, Inc.
- AngioDynamics, Inc. Reports Consolidated Goodwill Impairment for Third Quarter Ended February 29, 2024